Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about STRIATUM: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
STRIATUM is a concept in neurodegeneration research. Key relationships include: co discussed, associated with, inhibits. Associated with PARKINSON'S DISEASE. Connected to 23 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | STRIATUM |
| Key Genes/Proteins | AKT, AMPK, AMYLOID, AMYLOID-BETA, APP |
| Related Diseases | ALZHEIMER'S DISEASE, ANGIOGENESIS, APOPTOSIS |
Knowledge base pages for this entity
graph TD
STRIATUM["STRIATUM"]
STRIATUM -->|"expressed in"| dopaminergic_neurons["dopaminergic neurons"]
substantia_nigra_pars_compacta["substantia nigra pars compacta"] -->|"interacts"| STRIATUM
dopamine["dopamine"] -->|"expressed in"| STRIATUM
D1_medium_spiny_neurons["D1 medium spiny neurons"] -->|"expressed in"| STRIATUM
COMPLEMENT["COMPLEMENT"] -->|"activates"| STRIATUM
MICROGLIA["MICROGLIA"] -.protects against.-> STRIATUM
ATP["ATP"] -->|"expressed in"| STRIATUM
DRP1["DRP1"] -->|"expressed in"| STRIATUM
PRKAA1["PRKAA1"] -->|"expressed in"| STRIATUM
JUN["JUN"] -->|"expressed in"| STRIATUM
NRF1["NRF1"] -->|"expressed in"| STRIATUM
OPA1["OPA1"] -->|"expressed in"| STRIATUM| Target | Relation | Type | Str |
|---|---|---|---|
| dopaminergic neurons | expressed_in | cell_type | 0.70 |
| Huntington's disease | associated_with | disease | 0.70 |
| HUNTINGTON'S DISEASE | treats | disease | 0.65 |
| GAS6 | treats | gene | 0.65 |
| SUBSTANTIA NIGRA | produces | brain_region | 0.65 |
| INFLAMMATION | activates | phenotype | 0.65 |
| SUBSTANTIA NIGRA | increases | brain_region | 0.65 |
| NEUROINFLAMMATION | inhibits | phenotype | 0.65 |
| SUBSTANTIA NIGRA | expressed_in | brain_region | 0.65 |
| GDNF | activates | gene | 0.65 |
| SUBSTANTIA NIGRA | treats | brain_region | 0.65 |
| SIRT1 | activates | gene | 0.65 |
| SIRT1 | inhibits | gene | 0.65 |
| TUMOR | associated_with | disease | 0.60 |
| NEURODEGENERATION | implicated_in | disease | 0.55 |
| DOPAMINE | associated_with | concept | 0.50 |
| FRONTAL | associated_with | concept | 0.50 |
| DOPAMINERGIC NEURONS | activates | concept | 0.50 |
| PI3K/AKT/mTOR | activates | pathway | 0.50 |
| MTOR SIGNALING | activates | concept | 0.50 |
| INTERNEURONS | associated_with | concept | 0.50 |
| T CELL | co_discussed | entity | 0.50 |
| CEREBRAL CORTEX | associated_with | concept | 0.50 |
| CEREBRAL CORTEX | interacts_with | concept | 0.50 |
| SIRT1 | associated_with | gene | 0.50 |
| SIRT2 | associated_with | gene | 0.50 |
| SIRT3 | associated_with | gene | 0.50 |
| SIRT6 | associated_with | gene | 0.50 |
| SOD1 | associated_with | gene | 0.50 |
| GPX4 | associated_with | gene | 0.50 |
| TLR4 | co_discussed | entity | 0.50 |
| CEREBELLUM | associated_with | concept | 0.50 |
| SYNCRIP | regulates | concept | 0.50 |
| Proteins | regulates | protein | 0.50 |
| SYNCRIP | inhibits | concept | 0.50 |
| CEREBRAL CORTEX | inhibits | concept | 0.50 |
| Proteins | associated_with | protein | 0.50 |
| AMYGDALA | associated_with | concept | 0.50 |
| DOPAMINE | activates | concept | 0.50 |
| STROKE | co_discussed | entity | 0.50 |
| SUBSTANTIA NIGRA | depletes | brain_region | 0.50 |
| DOPAMINERGIC NEURONS | associated_with | concept | 0.50 |
| α-SYNUCLEIN | associated_with | concept | 0.50 |
| SNCA | associated_with | gene | 0.50 |
| PARKIN | associated_with | gene | 0.50 |
| CREB | associated_with | gene | 0.50 |
| NLRP3 | associated_with | gene | 0.50 |
| TLR4 | associated_with | gene | 0.50 |
| ULK1 | co_discussed | entity | 0.50 |
| VEGF | co_discussed | entity | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PARKINSON'S DISEASE | associated_with | disease | 1.00 |
| CORTEX | expressed_in | brain_region | 0.95 |
| ASeNG-ICA | targets | compound | 0.90 |
| Huntington's disease | affects | disease | 0.90 |
| Amyloid Beta | associated_with | protein | 0.90 |
| neurodegeneration | affects | disease | 0.90 |
| Parkinson's disease | affects | disease | 0.90 |
| SNCA | expressed_in | protein | 0.90 |
| SYP | expressed_in | protein | 0.90 |
| Spnphilin | expressed_in | protein | 0.85 |
| BDNF | expressed_in | gene | 0.80 |
| HUNTINGTON | disrupts | gene | 0.80 |
| dopamine receptor | expressed_in | receptor | 0.80 |
| RNA | expressed_in | gene | 0.80 |
| neuroinflammation | affects | disease | 0.80 |
| schizophrenia | affects | disease | 0.70 |
| Alzheimer's disease | affects | disease | 0.70 |
| GD3S | expressed_in | gene | 0.70 |
| dopamine | expressed_in | protein | 0.70 |
| depression | affects | disease | 0.70 |
| HTT | expressed_in | gene | 0.70 |
| LRRK2 | expressed_in | gene | 0.70 |
| D1 medium spiny neurons | expressed_in | cell_type | 0.70 |
| GFAP | expressed_in | gene | 0.70 |
| substantia nigra pars compacta | interacts_with | brain_region | 0.70 |
| TLR4 | expressed_in | gene | 0.70 |
| MICROGLIA | inhibits | cell_type | 0.66 |
| NEUROINFLAMMATION | activates | phenotype | 0.65 |
| TREM2 | activates | gene | 0.65 |
| GDNF | encodes | gene | 0.65 |
| TLR4 | activates | gene | 0.65 |
| TLR4 | inhibits | gene | 0.65 |
| NEURONS | causes | cell_type | 0.65 |
| GDNF | produces | gene | 0.65 |
| NEURON | causes | cell_type | 0.65 |
| NEURONS | regulates | cell_type | 0.65 |
| TH | causes | gene | 0.65 |
| PI3K | activates | gene | 0.65 |
| AKT | activates | gene | 0.65 |
| MTOR | activates | gene | 0.65 |
| NEURON | reduces | cell_type | 0.65 |
| HIPPOCAMPUS | expressed_in | brain_region | 0.65 |
| NEURON | inhibits | cell_type | 0.65 |
| DOPAMINERGIC | reduces | cell_type | 0.65 |
| SUBVENTRICULAR ZONE | causes | brain_region | 0.65 |
| NEURONS | reduces | cell_type | 0.65 |
| HTT | regulates | gene | 0.65 |
| NUCLEUS ACCUMBENS | activates | brain_region | 0.65 |
| TREM2 | exacerbates | gene | 0.65 |
| DOPAMINERGIC NEURONS | activates | cell_type | 0.65 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity